Indena, an Italian company that provides identification, development and production of active principles derived from plants—for use in the pharmaceutical, health-food and personal care industries—is selling its cosmetics business to Givaudan to focus on core markets, including the pharma side of its operations.   Within the pharma business, Indena recently expanded its CDMO offering to encompass new services. In particular, a kilolab to handle semisynthetic and total synthetic APIs that require...